GRAIL Inc. (GRAL) Earnings Dates & History
NASDAQ·Healthcare·Medical - Diagnostics & Research
$156.76
+4.08%
Mkt Cap $5.92B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $43.58M | $43.60M | +0.04% | -$3.33 | -$2.44 | +26.73% |
| Q4 2025 Nov 12, 2025 | $34.60M | $36.19M | +4.61% | -$3.36 | -$2.46 | +26.79% |
| Q3 2025 Aug 12, 2025 | $34.10M | $35.54M | +4.23% | -$3.14 | -$3.18 | -1.27% |
| Q2 2025 May 13, 2025 | $35.20M | $31.84M | -9.55% | -$4.03 | -$3.10 | +23.08% |
| Q1 2025 Feb 20, 2025 | $35.80M | $38.25M | +6.85% | -$4.41 | -$1.86 | +57.82% |
| Q4 2024 Nov 12, 2024 | $34.40M | $28.65M | -16.71% | -$6.43 | -$3.94 | +38.72% |
| Q3 2024 Aug 13, 2024 | — | $31.97M | — | — | -$5.30 | — |
| Q1 2024 Mar 31, 2024 | — | $26.72M | — | — | -$7.05 | — |
| Q4 2023 Dec 31, 2023 | — | $30.33M | — | — | -$0.18 | — |
| Q3 2023 Sep 30, 2023 | — | $20.72M | — | — | -$28.71 | — |
| Q2 2023 Jun 29, 2023 | — | $22.41M | — | — | -$6.22 | — |
| Q2 2023 Apr 2, 2023 | — | $19.64M | — | — | -$6.24 | — |
| Q3 2020 Sep 29, 2020 | — | — | — | — | -$0.58 | — |
| Q3 2019 Sep 29, 2019 | — | — | — | — | -$0.49 | — |